Miravo Healthcare Invites You to Join Us at the Q2 Virtual Investor Summit

Mississauga, Ontario--(Newsfile Corp. - May 11, 2021) - Miravo Healthcare (TSX: MRV) today announced that Jesse Ledger, President & CEO and Mary-Jane Burkett, Vice President & CFO will be attending the Q2 Virtual Investor Summit.

About Miravo Healthcare

About Miravo HealthcareMiravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.

For further information:

Miravo Healthcare
Stefan Eftychiou
905 326 1888 ext 60
stefan@bristolir.com

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

Contact:
Sasha Murray at sasha@investorsummitgroup.com